Volta

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

Unknown authors · 2025
hash_id: 3becc76acb9988753beb07f4e8d292d4b5d797f5ec67a24e9f299e8eb6e7b71d · DOI: 10.1002/14651858.cd013705.pub4

BACKGROUND: Accurate rapid diagnostic tests for SARS-CoV-2 infection could help manage the COVID-19 pandemic by potentially increasing access to testing and speed detection of infection, as well as informing clinical and public health management decisions to reduce transmission. Previous iterations of this review provided clear and conclusive evidence of superior test performance in those experiencing possible signs and symptoms of Covid-19. However, test performance in asymptomatic individuals and sensitivity by setting and indication for testing remains unclear. This is the fourth iteration of this review, first published in 2020. OBJECTIVES: To assess the diagnostic accuracy of rapid, point-of-care antigen tests (Ag-RDTs) for diagnosis of SARS-CoV-2 infection in asymptomatic population groups. SEARCH METHODS: We searched the COVID-19 Open Access Project living …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (3)

SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver Internat… primary
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection secondary
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… secondary